Copyright Reports & Markets. All rights reserved.

Global Non-Animal Softgel Capsules Supply, Demand and Key Producers, 2026-2032

Request for Sample of this report
Buy now

1 Supply Summary

  • 1.1 Non-Animal Softgel Capsules Introduction
  • 1.2 World Non-Animal Softgel Capsules Supply & Forecast
    • 1.2.1 World Non-Animal Softgel Capsules Production Value (2021 & 2025 & 2032)
    • 1.2.2 World Non-Animal Softgel Capsules Production (2021-2032)
    • 1.2.3 World Non-Animal Softgel Capsules Pricing Trends (2021-2032)
  • 1.3 World Non-Animal Softgel Capsules Production by Region (Based on Production Site)
    • 1.3.1 World Non-Animal Softgel Capsules Production Value by Region (2021-2032)
    • 1.3.2 World Non-Animal Softgel Capsules Production by Region (2021-2032)
    • 1.3.3 World Non-Animal Softgel Capsules Average Price by Region (2021-2032)
    • 1.3.4 North America Non-Animal Softgel Capsules Production (2021-2032)
    • 1.3.5 Europe Non-Animal Softgel Capsules Production (2021-2032)
    • 1.3.6 China Non-Animal Softgel Capsules Production (2021-2032)
    • 1.3.7 Japan Non-Animal Softgel Capsules Production (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Non-Animal Softgel Capsules Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Non-Animal Softgel Capsules Major Market Trends

2 Demand Summary

  • 2.1 World Non-Animal Softgel Capsules Demand (2021-2032)
  • 2.2 World Non-Animal Softgel Capsules Consumption by Region
    • 2.2.1 World Non-Animal Softgel Capsules Consumption by Region (2021-2026)
    • 2.2.2 World Non-Animal Softgel Capsules Consumption Forecast by Region (2027-2032)
  • 2.3 United States Non-Animal Softgel Capsules Consumption (2021-2032)
  • 2.4 China Non-Animal Softgel Capsules Consumption (2021-2032)
  • 2.5 Europe Non-Animal Softgel Capsules Consumption (2021-2032)
  • 2.6 Japan Non-Animal Softgel Capsules Consumption (2021-2032)
  • 2.7 South Korea Non-Animal Softgel Capsules Consumption (2021-2032)
  • 2.8 ASEAN Non-Animal Softgel Capsules Consumption (2021-2032)
  • 2.9 India Non-Animal Softgel Capsules Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

  • 3.1 World Non-Animal Softgel Capsules Production Value by Manufacturer (2021-2026)
  • 3.2 World Non-Animal Softgel Capsules Production by Manufacturer (2021-2026)
  • 3.3 World Non-Animal Softgel Capsules Average Price by Manufacturer (2021-2026)
  • 3.4 Non-Animal Softgel Capsules Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Non-Animal Softgel Capsules Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Non-Animal Softgel Capsules in 2025
    • 3.5.3 Global Concentration Ratios (CR8) for Non-Animal Softgel Capsules in 2025
  • 3.6 Non-Animal Softgel Capsules Market: Overall Company Footprint Analysis
    • 3.6.1 Non-Animal Softgel Capsules Market: Region Footprint
    • 3.6.2 Non-Animal Softgel Capsules Market: Company Product Type Footprint
    • 3.6.3 Non-Animal Softgel Capsules Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Non-Animal Softgel Capsules Production Value Comparison
    • 4.1.1 United States VS China: Non-Animal Softgel Capsules Production Value Comparison (2021 & 2025 & 2032)
    • 4.1.2 United States VS China: Non-Animal Softgel Capsules Production Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States VS China: Non-Animal Softgel Capsules Production Comparison
    • 4.2.1 United States VS China: Non-Animal Softgel Capsules Production Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Non-Animal Softgel Capsules Production Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States VS China: Non-Animal Softgel Capsules Consumption Comparison
    • 4.3.1 United States VS China: Non-Animal Softgel Capsules Consumption Comparison (2021 & 2025 & 2032)
    • 4.3.2 United States VS China: Non-Animal Softgel Capsules Consumption Market Share Comparison (2021 & 2025 & 2032)
  • 4.4 United States Based Non-Animal Softgel Capsules Manufacturers and Market Share, 2021-2026
    • 4.4.1 United States Based Non-Animal Softgel Capsules Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Non-Animal Softgel Capsules Production Value (2021-2026)
    • 4.4.3 United States Based Manufacturers Non-Animal Softgel Capsules Production (2021-2026)
  • 4.5 China Based Non-Animal Softgel Capsules Manufacturers and Market Share
    • 4.5.1 China Based Non-Animal Softgel Capsules Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Non-Animal Softgel Capsules Production Value (2021-2026)
    • 4.5.3 China Based Manufacturers Non-Animal Softgel Capsules Production (2021-2026)
  • 4.6 Rest of World Based Non-Animal Softgel Capsules Manufacturers and Market Share, 2021-2026
    • 4.6.1 Rest of World Based Non-Animal Softgel Capsules Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Non-Animal Softgel Capsules Production Value (2021-2026)
    • 4.6.3 Rest of World Based Manufacturers Non-Animal Softgel Capsules Production (2021-2026)

5 Market Analysis by Type

  • 5.1 World Non-Animal Softgel Capsules Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Carrageenan Softgel
    • 5.2.2 Starch Softgel
    • 5.2.3 Gellan Gum Softgel
  • 5.3 Market Segment by Type
    • 5.3.1 World Non-Animal Softgel Capsules Production by Type (2021-2032)
    • 5.3.2 World Non-Animal Softgel Capsules Production Value by Type (2021-2032)
    • 5.3.3 World Non-Animal Softgel Capsules Average Price by Type (2021-2032)

6 Market Analysis by Application

  • 6.1 World Non-Animal Softgel Capsules Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Health Supplements
    • 6.2.2 Pharmaceutical
    • 6.2.3 Others
  • 6.3 Market Segment by Application
    • 6.3.1 World Non-Animal Softgel Capsules Production by Application (2021-2032)
    • 6.3.2 World Non-Animal Softgel Capsules Production Value by Application (2021-2032)
    • 6.3.3 World Non-Animal Softgel Capsules Average Price by Application (2021-2032)

7 Company Profiles

  • 7.1 Catalent
    • 7.1.1 Catalent Details
    • 7.1.2 Catalent Major Business
    • 7.1.3 Catalent Non-Animal Softgel Capsules Product and Services
    • 7.1.4 Catalent Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Catalent Recent Developments/Updates
    • 7.1.6 Catalent Competitive Strengths & Weaknesses
  • 7.2 Procaps Laboratorios
    • 7.2.1 Procaps Laboratorios Details
    • 7.2.2 Procaps Laboratorios Major Business
    • 7.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Product and Services
    • 7.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Procaps Laboratorios Recent Developments/Updates
    • 7.2.6 Procaps Laboratorios Competitive Strengths & Weaknesses
  • 7.3 EuroCaps
    • 7.3.1 EuroCaps Details
    • 7.3.2 EuroCaps Major Business
    • 7.3.3 EuroCaps Non-Animal Softgel Capsules Product and Services
    • 7.3.4 EuroCaps Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.3.5 EuroCaps Recent Developments/Updates
    • 7.3.6 EuroCaps Competitive Strengths & Weaknesses
  • 7.4 Baihe
    • 7.4.1 Baihe Details
    • 7.4.2 Baihe Major Business
    • 7.4.3 Baihe Non-Animal Softgel Capsules Product and Services
    • 7.4.4 Baihe Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Baihe Recent Developments/Updates
    • 7.4.6 Baihe Competitive Strengths & Weaknesses
  • 7.5 Aenova
    • 7.5.1 Aenova Details
    • 7.5.2 Aenova Major Business
    • 7.5.3 Aenova Non-Animal Softgel Capsules Product and Services
    • 7.5.4 Aenova Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Aenova Recent Developments/Updates
    • 7.5.6 Aenova Competitive Strengths & Weaknesses
  • 7.6 Captek
    • 7.6.1 Captek Details
    • 7.6.2 Captek Major Business
    • 7.6.3 Captek Non-Animal Softgel Capsules Product and Services
    • 7.6.4 Captek Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Captek Recent Developments/Updates
    • 7.6.6 Captek Competitive Strengths & Weaknesses
  • 7.7 Sirio
    • 7.7.1 Sirio Details
    • 7.7.2 Sirio Major Business
    • 7.7.3 Sirio Non-Animal Softgel Capsules Product and Services
    • 7.7.4 Sirio Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Sirio Recent Developments/Updates
    • 7.7.6 Sirio Competitive Strengths & Weaknesses
  • 7.8 Bahrain Pharma
    • 7.8.1 Bahrain Pharma Details
    • 7.8.2 Bahrain Pharma Major Business
    • 7.8.3 Bahrain Pharma Non-Animal Softgel Capsules Product and Services
    • 7.8.4 Bahrain Pharma Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.8.5 Bahrain Pharma Recent Developments/Updates
    • 7.8.6 Bahrain Pharma Competitive Strengths & Weaknesses
  • 7.9 Robinson Pharma
    • 7.9.1 Robinson Pharma Details
    • 7.9.2 Robinson Pharma Major Business
    • 7.9.3 Robinson Pharma Non-Animal Softgel Capsules Product and Services
    • 7.9.4 Robinson Pharma Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.9.5 Robinson Pharma Recent Developments/Updates
    • 7.9.6 Robinson Pharma Competitive Strengths & Weaknesses
  • 7.10 Aland
    • 7.10.1 Aland Details
    • 7.10.2 Aland Major Business
    • 7.10.3 Aland Non-Animal Softgel Capsules Product and Services
    • 7.10.4 Aland Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Aland Recent Developments/Updates
    • 7.10.6 Aland Competitive Strengths & Weaknesses
  • 7.11 Fuji Capsule
    • 7.11.1 Fuji Capsule Details
    • 7.11.2 Fuji Capsule Major Business
    • 7.11.3 Fuji Capsule Non-Animal Softgel Capsules Product and Services
    • 7.11.4 Fuji Capsule Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.11.5 Fuji Capsule Recent Developments/Updates
    • 7.11.6 Fuji Capsule Competitive Strengths & Weaknesses
  • 7.12 Sunsho Pharmaceutical
    • 7.12.1 Sunsho Pharmaceutical Details
    • 7.12.2 Sunsho Pharmaceutical Major Business
    • 7.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product and Services
    • 7.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.12.5 Sunsho Pharmaceutical Recent Developments/Updates
    • 7.12.6 Sunsho Pharmaceutical Competitive Strengths & Weaknesses
  • 7.13 Erkang
    • 7.13.1 Erkang Details
    • 7.13.2 Erkang Major Business
    • 7.13.3 Erkang Non-Animal Softgel Capsules Product and Services
    • 7.13.4 Erkang Non-Animal Softgel Capsules Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.13.5 Erkang Recent Developments/Updates
    • 7.13.6 Erkang Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Non-Animal Softgel Capsules Industry Chain
  • 8.2 Non-Animal Softgel Capsules Upstream Analysis
    • 8.2.1 Non-Animal Softgel Capsules Core Raw Materials
    • 8.2.2 Main Manufacturers of Non-Animal Softgel Capsules Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Non-Animal Softgel Capsules Production Mode
  • 8.6 Non-Animal Softgel Capsules Procurement Model
  • 8.7 Non-Animal Softgel Capsules Industry Sales Model and Sales Channels
    • 8.7.1 Non-Animal Softgel Capsules Sales Model
    • 8.7.2 Non-Animal Softgel Capsules Typical Distributors

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    The global Non-Animal Softgel Capsules market size is expected to reach $ 652 million by 2032, rising at a market growth of 4.9% CAGR during the forecast period (2026-2032).
    Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.
    Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world. Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively. Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales. This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.
    This report studies the global Non-Animal Softgel Capsules production, demand, key manufacturers, and key regions.
    This report is a detailed and comprehensive analysis of the world market for Non-Animal Softgel Capsules and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Animal Softgel Capsules that contribute to its increasing demand across many markets.
    Highlights and key features of the study
    Global Non-Animal Softgel Capsules total production and demand, 2021-2032, (M Capsules)
    Global Non-Animal Softgel Capsules total production value, 2021-2032, (USD Million)
    Global Non-Animal Softgel Capsules production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Capsules), (based on production site)
    Global Non-Animal Softgel Capsules consumption by region & country, CAGR, 2021-2032 & (M Capsules)
    U.S. VS China: Non-Animal Softgel Capsules domestic production, consumption, key domestic manufacturers and share
    Global Non-Animal Softgel Capsules production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Capsules)
    Global Non-Animal Softgel Capsules production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Capsules)
    Global Non-Animal Softgel Capsules production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Capsules)
    This report profiles key players in the global Non-Animal Softgel Capsules market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Procaps Laboratorios, EuroCaps, Baihe, Aenova, Captek, Sirio, Bahrain Pharma, Robinson Pharma, Aland, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Animal Softgel Capsules market
    Detailed Segmentation:
    Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Capsules) and average price (US$/Capsule) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
    Global Non-Animal Softgel Capsules Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World
    Global Non-Animal Softgel Capsules Market, Segmentation by Type:
    Carrageenan Softgel
    Starch Softgel
    Gellan Gum Softgel
    Global Non-Animal Softgel Capsules Market, Segmentation by Application:
    Health Supplements
    Pharmaceutical
    Others
    Companies Profiled:
    Catalent
    Procaps Laboratorios
    EuroCaps
    Baihe
    Aenova
    Captek
    Sirio
    Bahrain Pharma
    Robinson Pharma
    Aland
    Fuji Capsule
    Sunsho Pharmaceutical
    Erkang
    Key Questions Answered:
    1. How big is the global Non-Animal Softgel Capsules market?
    2. What is the demand of the global Non-Animal Softgel Capsules market?
    3. What is the year over year growth of the global Non-Animal Softgel Capsules market?
    4. What is the production and production value of the global Non-Animal Softgel Capsules market?
    5. Who are the key producers in the global Non-Animal Softgel Capsules market?
    6. What are the growth factors driving the market demand?

    Buy now